2023. Eosinophilic granulomatosis with polyangiitis: sequential use of mepolizumab following rituximab for inadequate asthma control despite vasculitis remission. Reumatismo. 75, 4 (Dec. 2023). DOI:https://doi.org/10.4081/reumatismo.2023.1588.